AMGEN INC Accounts Payable 2008-2026 | AMGN
Beta
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is AMGEN INC's current accounts payable?
AMGEN INC (AMGN) annual accounts payable for 2025 was $2.37B, a 24.06% increase from 2024. AMGEN INC accounts payable for the quarter ending March 31, 2026 was $2.94B.
What was AMGEN INC's accounts payable in 2024?
AMGEN INC annual accounts payable for 2024 was $1.91B, a 20.00% increase from 2023.
What was AMGEN INC's accounts payable in 2023?
AMGEN INC annual accounts payable for 2023 was $1.59B, a 1.15% increase from 2022.
What is AMGEN INC's 5-year accounts payable CAGR?
AMGEN INC accounts payable grew at a compound annual growth rate (CAGR) of 10.74% from FY2020 to FY2025, going from $1.42B to $2.37B over 5 years.
Accounts Payable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+10.7%
FY2020
$1.42B
→
FY2025
$2.37B
080910111213141516171819202122232425
5 years selected
Accounts Payable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.37B | +24.1% | 10-K |
| FY2024 | $1.91B | +20.0% | 10-K |
| FY2023 | $1.59B | +1.1% | 10-K |
| FY2022 | $1.57B | +15.1% | 10-K |
| FY2021 | $1.37B | -3.9% | 10-K |
| FY2020 | $1.42B | +3.6% | 10-K |
| FY2019 | $1.37B | +13.6% | 10-K |
| FY2018 | $1.21B | -10.7% | 10-K |
| FY2017 | $1.35B | +47.4% | 10-K |
| FY2016 | $917.0M | -5.0% | 10-K |
| FY2015 | $965.0M | -3.0% | 10-K |
| FY2014 | $995.0M | +26.4% | 10-K |
| FY2013 | $787.0M | -13.0% | 10-K |
| FY2012 | $905.0M | +41.0% | 10-K |
| FY2011 | $642.0M | -10.3% | 10-K |
| FY2010 | $716.0M | +24.7% | 10-K |
| FY2009 | $574.0M | +13.9% | 10-K |
| FY2008 | $504.0M | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →